FDAnews
www.fdanews.com/articles/122957-elan-receives-first-japanese-product-approval-using-nanocrystal-technology

Elan Receives First Japanese Product Approval Using NanoCrystal Technology

December 14, 2009
Elan Drug Technologies, a business unit of Elan Corporation, plc announces the approval by the Japanese Ministry of Health, Labour and Welfare of EMEND (aprepitant) for the treatment of cancer chemotherapy-induced nausea and vomiting.
Benzinga